"Altru Health System is a community of over 4,000 health professionals and support staff committed to caring for the region for more than 100 years. Meeting the needs and expectations of our patients is our highest priority."

During the past decade, Altru Health Systems conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altru Health Systems" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 39 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Mayo Clinic" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altru Health Systems" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Altru Health Systems" are "Lung Cancer" (11 trials), "Breast Cancer" (9 trials), "Colorectal Cancer" (9 trials), "Lymphoma" (6 trials) and "Brain and Central Nervous System Tumors" (4 trials). Many other conditions were trialed in "Altru Health Systems" in a lesser frequency.

Most popular intervention types in "Altru Health Systems" are "Drug" (52 trials), "Other" (13 trials), "Radiation" (13 trials), "Device" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (8 trials), "radiation therapy" (8 trials), "fluorouracil" (7 trials), "cisplatin" (6 trials) and "leucovorin calcium" (6 trials). Other intervention names were less common.

The vast majority of trials in "Altru Health Systems" are 59 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Altru Health Systems". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 62 completed trials in Altru Health Systems, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Altru Health Systems, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".

Altru Health Systems has several departments that took part in Clinical trials: "Altru Cancer Center" - 170 trials